Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
New England Journal of Medicine
•
March 30, 2026
Sirolimus balloons reduce limb events
Sirolimus-coated balloon angioplasty reduced major limb events at 1 year versus uncoated balloon angioplasty. *Randomized noninferiority trial; Level 2 (OCEBM).
- Level of evidence
- Level 2 (OCEBM)
- DocG quality score
- 8.1 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
